J Mult Scler Neuroimmunol.
2023 Dec;14(2):106-109. 10.59578/jmsni.2023.14.2.106.
Central Hyperthemia Treated with Bromocriptine in a Patient with Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorder
- Affiliations
-
- 1Department of Neurology, Chungnam National University Hospital, Daejeon, Korea
- KMID: 2561987
- DOI: http://doi.org/10.59578/jmsni.2023.14.2.106
Abstract
- Central hyperthermia occurs due to lesions in the thermoregulatory center caused by brain injury or stroke; however, it is uncommon in demyelinating diseases. It is known to poorly respond to antipyretics, and its occurrence is associated with a poor prognosis. While there is no established treatment for central hyperthermia, recent reports highlight successful management with bromocriptine. We present a case of hyperthermia arising from lesions in the medulla in a patient with aquaporin 4 antibody positive neuromyelitis optica spectrum disorder.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Monoclonal Antibody Therapies for Neuromyelitis Optica Spectrum Disorder
- Isolated Tongue Paralysis as Presentation of Seropositive Neuromyelitis Optica Spectrum Disorder
- Neuromyelitis optica spectrum disorders with an inverted V sign on spinal cord magnetic resonance imaging: antiaquaporin-4 antibody and functional vitamin B12 deficiency
- A Case of Neuromyelitis Optica Spectrum Disorder of a Patient Who Present for Fungal Sinusitis
- Postpartum Relapse of Neuromyelitis Optica Spectrum Disorder after a Long Period of Spontaneous Remission
